TiO2 nanoparticles tested in a novel screening whole human blood model of toxicity trigger adverse activation of the kallikrein system at low concentrations.

MLA

Ekstrand-Hammarström, Barbro, et al. “TiO2 Nanoparticles Tested in a Novel Screening Whole Human Blood Model of Toxicity Trigger Adverse Activation of the Kallikrein System at Low Concentrations.” Biomaterials, vol. 51, May 2015, pp. 58–68. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2015.01.031.

APA

Ekstrand-Hammarström, B., Hong, J., Davoodpour, P., Sandholm, K., Ekdahl, K. N., Bucht, A., & Nilsson, B. (2015). TiO2 nanoparticles tested in a novel screening whole human blood model of toxicity trigger adverse activation of the kallikrein system at low concentrations. Biomaterials, 51, 58–68. https://doi.org/10.1016/j.biomaterials.2015.01.031

Chicago

Ekstrand-Hammarström, Barbro, Jaan Hong, Padideh Davoodpour, Kerstin Sandholm, Kristina N. Ekdahl, Anders Bucht, and Bo Nilsson. 2015. “TiO2 Nanoparticles Tested in a Novel Screening Whole Human Blood Model of Toxicity Trigger Adverse Activation of the Kallikrein System at Low Concentrations.” Biomaterials 51 (May): 58–68. doi:10.1016/j.biomaterials.2015.01.031.